Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1998 1
1999 1
2001 1
2002 1
2003 1
2004 4
2005 2
2006 2
2007 13
2008 13
2009 11
2010 6
2011 10
2012 24
2013 26
2014 28
2015 19
2016 20
2017 23
2018 25
2019 16
2020 18
2021 12
2022 16
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 25505113

246 results

Results by year

Filters applied: . Clear all
Page 1
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG. Guindon J, et al. Pharmacol Res. 2013 Jan;67(1):94-109. doi: 10.1016/j.phrs.2012.10.013. Epub 2012 Nov 2. Pharmacol Res. 2013. PMID: 23127915 Free PMC article.
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH. Kinsey SG, et al. J Pharmacol Exp Ther. 2009 Sep;330(3):902-10. doi: 10.1124/jpet.109.155465. Epub 2009 Jun 5. J Pharmacol Exp Ther. 2009. PMID: 19502530 Free PMC article.
Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
Slivicki RA, Saberi SA, Iyer V, Vemuri VK, Makriyannis A, Hohmann AG. Slivicki RA, et al. J Pharmacol Exp Ther. 2018 Dec;367(3):551-563. doi: 10.1124/jpet.118.252288. Epub 2018 Oct 1. J Pharmacol Exp Ther. 2018. PMID: 30275151 Free PMC article.
246 results